🟢 Insmed is trading 29.8% up in after-hours trading with no confirmed catalyst identified

Insmed is trading at $124.94, up +29.78% after hours, with no confirmed company-specific announcement explaining the move.

• Available reporting said no new catalyst was detected on October 16.
• Insmed’s respiratory-program presentations at CHEST 2026 and IDWeek were announced before the move and do not establish its cause.
• Broader markets were sharply lower, which does not explain the gain as a market-wide move.